| 000 | 01601 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518015919.0 | ||
| 264 | 0 | _c20190613 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2019.01.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMielczarek, Lidia | |
| 245 | 0 | 0 |
_aIn the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cMar 2019 |
||
| 300 |
_a311-318 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsothiocyanates _xadministration & dosage |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aSulfoxides |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aKrug, Pamela | |
| 700 | 1 | _aMazur, Maciej | |
| 700 | 1 | _aMilczarek, Małgorzata | |
| 700 | 1 | _aChilmonczyk, Zdzisław | |
| 700 | 1 | _aWiktorska, Katarzyna | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 558 _gp. 311-318 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2019.01.008 _zAvailable from publisher's website |
| 999 |
_c29252262 _d29252262 |
||